Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b/3, Double-masked, Randomized, Vehicle-controlled, Multicenter Study Evaluating Licaminlimab in Dry Eye Disease Patients With a Specific TNFR1 Genotype

NCT07548632 is registered in ClinicalTrials.gov with Oculis as lead sponsor.

NCT NCT07548632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07548632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b/3, Double-masked, Randomized, Vehicle-controlled, Multicenter Study Evaluating Licaminlimab in Dry Eye Disease Patients With a Specific TNFR1 Genotype
Lead sponsor
Oculis
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 16, 2026
Completion date
December 31, 2026
Enrollment
160 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)